Chapitre 1
The Quest for a Slimmer Society: Inside the Weight-Loss Drug Revolution
In winter 2022, I attended my first post-lockdown party hosted by an Oscar-winning actor and was stunned to find everyone looking remarkably thinner. When I commented that everyone must have taken up Pilates, a friend laughed and showed me a light blue plastic tube with a tiny needle: Ozempic. This moment felt like one I'd been waiting for all my life, especially after that heartbreaking Christmas Eve in 2009 when my local KFC staff presented me with a massive card addressed "To our best customer."
The search for weight-loss solutions dates back to ancient Greece, but experts claim these new drugs are different. Professor Tim Spector calls them "the Holy Grail" for severe obesity, with financial analysts comparing their societal impact to the smartphone's invention. Nearly half of Americans report willingness to take these drugs, with projections suggesting 20-30% of Britons will use them within a decade-potentially creating a $200 billion global market by 2030.
Yet I felt deeply conflicted. While obesity kills between 112,000-678,000 Americans annually-far exceeding gun deaths-I questioned treating a societal problem with biological solutions. Our obesity epidemic didn't emerge from disease but from transformed food systems, unwalkable cities, and increased stress. Are we simply injecting one poison to counter another? We know little about long-term effects, and scientists aren't entirely sure why these drugs work.
Chapitre 2
The Miracle Mechanism: How GLP-1 Drugs Transform Bodies and Minds
My first week on Ozempic felt strange-my usual ravenous morning hunger had completely vanished. At my regular cafe, I could barely eat a few bites of my usual chicken roll before feeling full. Throughout that week, it felt like shutters had come down on my appetite, allowing only tiny peeks of light through. I experienced mild nausea, exaggerated travel sickness, and became full startlingly fast-as if I'd just finished Christmas dinner when offered another meal.
The science behind these extraordinary effects began in 1984 when Canadian researcher Daniel Drucker started investigating the glucagon gene in a shabby Massachusetts lab. Initially disappointed with his assignment, Drucker discovered that GLP-1, a snippet of genetic code, could stimulate insulin production when isolated-potentially significant for diabetes treatment.
Meanwhile in London, Dr. John Wilding encountered a patient so obese he needed to be removed from his home by crane. Scientists discovered GLP-1 levels spike in the gut after eating, potentially signaling fullness. However, since GLP-1 disappears quickly from the system, interest waned until biochemist John Eng noticed GLP-1's striking similarity to a chemical in the venom of America's deadliest lizard, the Gila monster.
Unlike human GLP-1 which degrades within minutes, the lizard venom version lasts for hours. This discovery enabled pharmaceutical companies to develop "agonists" that could remain in the system for a week. These drugs were approved for diabetics in 2005, but researchers soon noticed patients were also losing significant weight.
Novo Nordisk's trials revealed that obese patients taking semaglutide for 68 weeks lost an average of 15% of their body weight-making it the most successful weight-loss drug in history. However, studies showed that after stopping the medication, most people regained two-thirds of lost weight within a year, meaning these drugs require lifelong use.
In my first six months on Ozempic, I lost 35 pounds, going from obese to the upper end of a healthy weight. While I felt lighter and more confident, I also experienced persistent side effects: waves of nausea, nighttime burping, constipation, elevated heart rate causing anxiety, and afternoon dizziness. For 5-10% of users, these side effects prove too extreme to continue the treatment.
Chapitre 3
The Perfect Obesity Storm: Why We Gained Weight
Around 1979, an unprecedented shift began in human history-obesity rates skyrocketed. Between 1979 and 2000, obesity more than doubled in the United States from 15% to 30.9%, with severe obesity nearly doubling in the following twenty years. The average American now weighs 23 pounds more than in 1960, with over 70% of Americans overweight or obese. This global phenomenon has nearly tripled worldwide since 1975, affecting both developed and developing nations, not because of genetic shifts or declining willpower, but due to profound environmental changes. Even countries traditionally known for healthy diets, like Japan and Mediterranean nations, have seen significant increases in obesity rates.
My father felt "catapulted without his consent out of a healthy food culture into a sick one," creating tension as his children embraced processed foods. Growing up in the 1960s, his meals consisted of home-cooked dishes made from whole ingredients. By contrast, his children's generation faced an onslaught of convenient, heavily marketed processed foods. In this stressful environment, I found comfort in unrestricted consumption, particularly through "stuffing"-eating beyond fullness to feel the physical sensation of being stretched inside. Despite consuming vast amounts of processed snacks and fast food daily, including entire packages of cookies and family-sized bags of chips, I remained thin until my late teens, believing multivitamins magically canceled out poor nutrition.
While I imagined processed foods came from large-scale kitchens, journalist Joanna Blythman's investigation revealed manufacturing facilities resembling oil refineries or missile launch pads. These factories don't "cook" but "manufacture" food by assembling chemical components in massive industrial operations. A typical strawberry milkshake contains fifty chemicals for flavoring alone-with no actual strawberries-including ethyl methylphenylglycidate for "strawberry" notes and ethyl acetate for "ethereal" effects. This processing serves to extend shelf life by pumping products full of sugar, fat, and salt, often disguised under dozens of different names on labels. Food scientists carefully engineer "bliss points"-moments of sugar kicks or mouth excitement-creating an unnatural deliciousness that trains palates to crave these chemical combinations. These formulations are tested extensively using sophisticated sensory analysis and brain imaging to maximize their appeal.
Neuroscientist Paul Kenny's experiments revealed even more disturbing effects about processed food's impact on behavior and brain function. When rats were trained to associate a yellow light with electric shocks, those eating standard rat chow fled when shown the light without shocks. However, rats eating cheesecake ignored the warning and continued eating, demonstrating how processed foods can override even powerful survival instincts. Similar experiments consistently show processed foods creating abnormal behaviors in rats-even naturally skinny rats bred to resist obesity became obese on high-fat, high-sugar diets. The rats showed signs of addiction similar to those seen with drugs, including withdrawal symptoms when the processed foods were removed and diminished pleasure response to normal foods. These findings suggest processed foods don't just make us fat; they fundamentally alter our relationship with eating and survival behaviors.
Chapitre 4
When Fullness Disappears: How Modern Food Hijacked Our Bodies
Ultra-processed foods have transformed our relationship with eating, creating a culture where McDonald's golden arches are more recognized worldwide than the Christian cross. Harvard nutrition professor Jerold Mande explains that modern food has been redesigned to override our body's natural signals to stop eating, creating the need for weight-loss drugs.
Research by Susanna Holt at the University of Sydney revealed that whole foods create lasting fullness, while processed foods leave us perpetually hungry. Professor Tim Spector identified seven specific mechanisms that undermine satiety: First, ultra-processed foods require less chewing, preventing proper fullness signals. Second, they combine sugar, fat, and carbs-a combination naturally found only in breast milk, triggering primal cravings. Third, they cause blood sugar roller coasters repeatedly triggering hunger. Fourth, they lack protein and fiber, causing us to overeat. Fifth, liquid calories from sodas are easily overconsumbed. Sixth, artificial sweeteners trick the brain-when it expects sugar but doesn't receive it, it responds by increasing hunger. The seventh factor is that processed food has separated flavor from nutritional value, scrambling our "nutritional wisdom" that evolved over hundreds of thousands of years.
The agricultural industry's methods for fattening animals mirror what's happening to humans. Factory farms have dramatically accelerated weight gain in livestock by restricting movement and transforming diets from natural foods to ultra-processed feed containing grains, chemicals, hormones, antibiotics, and artificial sweeteners. As Tim Spector warns, we're living in a "perfect obesity storm" where ultra-processed food would be banned if it were classified as a drug due to its dangers.
Many obesity experts warn against relying solely on pharmaceutical solutions while neglecting environmental causes, but personal stories challenge this philosophical stance. When my friend Judy argued, "If my house is on fire... right now, the house is on fire. Call a fire engine, and douse the whole house in water," she emphasized that immediate intervention doesn't preclude long-term solutions. Jeff Parker, who lost fifty pounds on Mounjaro, saw his health dramatically improve-reducing medications for blood pressure, gout, and cholesterol. When challenged about addressing root causes, he responded pragmatically: "I'm all for rebuilding the food supply... but I live today, not in some future utopia... Life is a finite resource."
Chapitre 5
The Hidden Dangers of Inflammation
Contrary to common misconceptions that diabetes is manageable with insulin injections, the disease has devastating consequences. As body mass increases, so does diabetes risk-those with a BMI over 35 at age eighteen face over 70% lifetime risk of developing diabetes. The condition develops with shocking speed; in one experiment, healthy men developed insulin resistance within just 48 hours of consuming 6,000 calories daily while bedridden. Currently, more than a third of Americans are pre-diabetic, with 12-14 percent having full-blown diabetes.
Excess weight damages the body in numerous ways beyond diabetes. It causes physical pain by straining backs, knees, and hips, severely limiting mobility and quality of life. The damage compounds with age-overweight men are 176% more likely to need joint replacements, while obese men face 320% higher odds. Obesity endangers the heart by narrowing blood vessels, increasing blood pressure, and promoting atherosclerosis. For every five-unit BMI increase, heart failure risk rises 41%, with obesity-attributed heart disease deaths tripling between 1999-2020. Cancer risk rises significantly too-4-8% of all cancers are attributable to obesity, with strong evidence linking it to nine different cancer types.
Inflammation is crucial for understanding obesity's harm. Normally, inflammation is a healing response that resolves when injury heals. But as fat cells reach their expansion limit, the body senses this stretching as damage and triggers inflammation that never subsides. This chronic inflammation disrupts the immune system and healing processes, contributing to cancer and numerous other conditions including asthma, sleep apnea, arthritis, kidney problems, fertility issues, gallstones, thrombosis, and dementia.
Evidence from bariatric surgery demonstrates that weight loss can reverse many obesity-related health problems. After surgery, 75% of diabetic patients see their condition vanish, 60% overcome hypertension, and two-thirds find their back pain disappears. More dramatically, mortality from diabetes falls 92%, cancer deaths drop 60%, and heart disease mortality decreases 56%. Similar benefits are emerging with GLP-1 drugs-a five-year study of 17,000 adults taking Wegovy showed 20% reductions in heart attacks and strokes, plus improvements across 28 health measures.
Chapitre 6
The Dangerous History of Weight Loss Drugs
In the twentieth century, a disturbing pattern emerged with weight-loss drugs: miracle treatments would appear, demonstrate remarkable effectiveness, gain widespread popularity, then reveal devastating fatal flaws requiring their immediate withdrawal. This cycle of hope and disaster has repeated itself multiple times, leaving a trail of damaged lives and cautionary tales in medical history.
The first modern diet drug emerged accidentally during World War I when munitions workers handling dinitrophenol experienced unexplained rapid weight loss. Stanford scientists subsequently discovered it could cause dramatic two-pound weekly weight loss by boosting metabolism 30-50%. Marketed under the brand name "Redusols," it attracted over 100,000 eager users by 1934. However, the side effects were severe: users experienced profuse sweating that soaked through clothes, complete loss of taste sensation, and permanent cataracts. In the most severe cases, patients developed fatal hyperpyremia - literally cooking from the inside out as their body temperature rose uncontrollably. Despite these dangers, black market versions continued to circulate for decades.
The post-World War II era ushered in the age of amphetamines as weight-loss drugs. Initially used by soldiers for combat alertness, their appetite-suppressing effects led to widespread civilian use for weight control. By 1952, pharmaceutical companies manufactured approximately 2 billion amphetamine pills yearly for weight loss. The scale was staggering - by 1970, amphetamine prescriptions represented 8% of all US prescriptions written. The consequences were severe: users quickly developed tolerance, requiring ever-increasing doses that led to a cascade of serious effects including severe paranoia, crippling anxiety, acute psychosis, and permanent heart damage. Many patients developed life-threatening addictions.
The 1990s brought what seemed like a breakthrough with fen-phen, a combination of fenfluramine and phentermine. After a small initial study showing average thirty-pound weight loss, media outlets enthusiastically proclaimed it a "miracle drug," driving demand to astronomical levels with 18 million prescriptions by 1995. The tragic case of Mary Linnen became emblematic of its dangers - a healthy 30-year-old bride-to-be who took fen-phen to lose weight for her wedding developed primary pulmonary hypertension within days and died shortly after. Subsequent investigations revealed the drug caused heart valve defects in one-third of users and increased pulmonary hypertension risk thirtyfold. The resulting lawsuits cost pharmaceutical companies over $12 billion - the largest settlement in medical history at that time.
Today's generation of weight-loss drugs, while developed by reputable companies with rigorous testing protocols, are revealing their own concerning patterns. Twelve significant risks have emerged, including cosmetic effects dubbed "Ozempic face" (facial aging) and "Ozempic butt" (rapid loss of gluteal fat). More alarming is research showing patients taking GLP-1 drugs for 1-3 years face a 50-75% higher risk of developing thyroid cancer compared to non-users. Additional serious complications include acute pancreatitis, gastric paralysis, dangerous muscle mass deterioration, and severe malnutrition. The popularity of these drugs has created supply shortages affecting diabetic patients who depend on them for blood sugar control. A flourishing black market of counterfeit products has emerged, adding another layer of risk. Perhaps most concerning are the unknown long-term effects that might take decades to fully manifest, echoing the pattern of previous "miracle" weight loss drugs.
Chapitre 7
Beyond Pills: The Failure of Traditional Approaches
When faced with obesity, we're traditionally offered three solutions: exercise, diet, and implicit stigma. The recipe seems simple-eat less, move more, and feel bad if you don't. But this approach has largely failed us, despite its apparent logic.
While diets initially work because of the simple physics of calorie deficits, research reveals a startling truth: they ultimately fail for most people. The fundamental problem lies in our biology-as we gain weight, our body establishes a new "acquired set point" it will fight to defend. When we try to lose weight, our metabolism slows, hormone levels change to increase hunger while decreasing fullness, and our brains become preoccupied with food. This evolved as a survival mechanism against famine, but in today's food-abundant environment, it works against us. Studies show dismal long-term results: after five years, the average structured weight-loss program participant loses only about 3% of body weight, with only about 20% of dieters maintaining significant weight loss for a year or more.
Iceland's Youth in Iceland initiative, designed by Thorolfur, offered a fundamentally different approach to youth health problems. Every child received government vouchers twice yearly to participate in sports, dance, or music. The results were impressive-youth centers across Reykjavik offered eleven different sports, with facilities like Olympic-quality basketball courts, ice-skating rinks, and gymnastics rooms open until at least 10 p.m. daily. Participation rates soared, and the program dramatically reduced teen drinking from 42% to just 5%, with similar declines in smoking and drug use.
Yet paradoxically, despite having Europe's most successful exercise program, youth obesity in Iceland continued to rise dramatically. This aligns with broader research showing exercise rarely causes sustained weight loss-an Arizona State University study found 55 of 81 women gained weight after three months of regular treadmill walking. Scientists explain that the calories burned through exercise are easily overwhelmed by increased caloric intake, and we vastly overestimate how much exercise is needed to offset food consumption. While exercise prevents numerous diseases and extends lifespan, it simply doesn't work well for weight loss.
Chapitre 8
The Hidden Psychological Costs of Weight Loss
After everything I learned about how these drugs affect the brain, I wondered if my low mood since starting Ozempic stemmed from biological changes to my reward centers or perhaps from psychological effects. I began researching and discovered scientific evidence for at least five distinct reasons why we eat. Slowly, I realized that Ozempic had disrupted almost all of these functions for me.
The first reason is basic survival-we eat to sustain our bodies. But Ozempic revealed how little of my relationship with food was driven by this urge. Before the drug, I consumed 3,200 calories daily; after, I functioned perfectly well on 1,800.
The second reason is pleasure. Many on these drugs report food becoming joyless and utilitarian. Experts like Harvard nutritionist Jerold Mande worry about removing this fundamental pleasure from human experience, potentially triggering depression or risky pleasure-seeking elsewhere.
The third reason is comfort and self-soothing. We eat to calm ourselves during stress-after lost football games, elections, traumatic events, or personal disasters. This explains higher obesity rates among poorer people and marginalized groups experiencing chronic stress. Ozempic stripped away this coping mechanism, leaving me "naked before the pain" without my usual shock absorber during a period of personal tragedies.
The fourth reason involves reenacting childhood psychological patterns. Psychoanalyst Hilde Bruch discovered how early "programming" around food shapes lifelong eating habits. I realized I had unconsciously carried forward childhood associations of healthy food with shame and unhealthy food with love. When Ozempic pushed me toward healthier eating, I experienced it not as liberation but as frightening deprivation-I felt I was being deprived not just of junk food, but of love itself.
The fifth reason we eat is perhaps the most challenging-being overweight can psychologically protect us. Dr. Vincent Felitti discovered this while researching obesity at Kaiser Permanente. When one patient named Susan lost significant weight through a medically supervised fasting program, she suddenly began overeating again after a man showed interest in her. It emerged she had started gaining weight at age ten when her grandfather began sexually abusing her. "Overweight is overlooked," she explained, "and that's the way I need to be."
About one in ten bariatric surgery patients develop "addiction transfers"-their obsession with food shifts to alcohol, gambling, shopping, or drugs. As Dr. Carel Le Roux explains, overeating performs a psychological function, and afterward, "there's this hole, this space, left in their reward areas." Studies show 17 percent of bariatric surgery patients experience depression and anxiety severe enough to require inpatient psychiatric treatment, and suicide rates increase fourfold. This made me wonder if Ozempic might trigger similar responses in some users.
Chapitre 9
Toward a Balanced Future: Lessons from Japan and Beyond
At Tanita, a health-focused company in Japan, employees gather every morning for group exercises with elastic bands. The company's boss, Junya Nagasawa, consistently leads their walking challenge with nearly 20,000 steps daily. When Japan's Metabo Law required companies to monitor employee health, Tanita developed health surveillance systems and implemented them internally first.
The Metabo Law requires annual health checks, with government-funded specialist support for employees gaining weight. Companies with increasingly overweight workforces face fines-electronics giant NEC estimated potential penalties of $19 million, prompting extensive changes. The approach focuses on awareness rather than coercion: "measure, understand, realize, and change." Employees share their health data publicly, creating collective accountability and motivation.
Japanese culture creates barriers against overeating at every life stage. Fast food exists but remains a treat, not a staple. The results are striking: elderly Japanese gather in parks daily for exercise, with men living to 81 and women to 86 on average. More importantly, while Americans and Britons spend 16-19 years in poor health before death, Japanese people experience only 5-6 years of ill health.
In Ogimi village, Okinawa-possibly the world's longest-lived community-I met 102-year-old Matsu Fukuchi, who walked with a cane to the community center where she still dances. When asked about her longevity secret, she said it happened naturally despite poverty: "I ate potato leaves, miso soup, and soft-cooked rice... I eat vegetables."
The obesity crisis is artificial-created by our lifestyle and therefore possible to un-create. Just as smoking transformed from ubiquitous to rare within a generation (from 71% of men in 1982 to 12% overall today), our food culture could change dramatically. Evidence from Mexico's sugary drink tax and Amsterdam's childhood obesity initiative (which reduced rates by 12% overall and 18% among the poorest children) shows that meaningful change is possible through deliberate policy interventions.
We can take concrete actions to improve our food environment, as demonstrated by successful initiatives worldwide. Amsterdam launched a comprehensive program targeting childhood obesity through banning unhealthy school foods, replacing sugary drinks with water, increasing exercise programs, and providing coaches to parents with obese children. In Minneapolis, doctors began "prescribing" free healthy food to patients, resulting in significantly improved health after six months. Britain's food companies were persuaded to reduce salt in bread-an unnoticeable change that saves thousands of lives annually from strokes.
I've gradually formed firmer convictions about weight-loss drugs while working on this book. First, we must radically change our food environment so future generations don't become hooked on processed, satiety-sapping foods. Second, while we fight for that change, we must weigh the risks of obesity against the risks of these drugs in our imperfect present. My tentative conclusion: those with BMI under 27 shouldn't take these drugs; those over 35 without thyroid cancer history probably should; those between 27-35 face a more balanced decision. Third, we need urgent measures to prevent these drugs causing harm to vulnerable people, particularly those with eating disorders.
These examples prove we have alternatives beyond choosing between obesity and weight-loss drugs. We can create healthier food environments, but it will only happen if enough people demand it.
